Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Jun 24
 -13.06 / -4.98%
Today’s Change
Today|||52-Week Range
IBB Regular Dividend: IBB began trading ex-dividend on 06/21/16. A $0.1622 dividend will be paid to shareholders of record as of 06/23/16.

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by NASDAQ OMX. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Can Gilead Sciences Rebound in the Second Half of 2016?
Jun 25 / MotleyFool.com - Paid Partner Content
Jun 21 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy in the Wake of the Brexit Vote
Jun 24 / MotleyFool.com - Paid Partner Content
Biotech's BioWreck
Jun 21 / TheStreet.com - Paid Partner Content
A Prescription for More Biotech Pain
Jun 23 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: Tech Selloff Hints At Reasons to Go Long
Jun 20 / TheStreet.com - Paid Partner Content


1 month-1.40% 3 years+16.00%
3 months+3.23% 5 years+20.49%
1 year-31.53% Since inception+6.61%
Data through 06/24/2016

Quote Details

Previous close$262.10
Open day’s range248.83 – 256.35
Net asset value (NAV)262.04 (06/23/2016)
Daily volume3,854,877
Average volume (3 months)1,985,893
Data as of 4:00pm ET, 06/24/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+20.49%+15.78%
Expense Gross exp ratio0.48%0.48%
Risk 5 year sharpe ratio0.990.98
Net assets$6.8B$1.2B
Average market cap$14.4B$36.0B
Average P/E20.924.4
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen8.15%
AMGN Amgen8.10%
CELG Celgene7.64%
REGN Regeneron Pharmaceuticals7.29%
GILD Gilead Sciences7.29%
VRTX Vertex Pharmaceuticals Inc3.98%
ALXN Alexion Pharmaceuticals Inc3.91%
ILMN Illumina Inc3.52%
MYL Mylan NV3.51%
INCY Incyte Corp3.00%

Partner Offers

Search for Jobs